Company / Total Assets
RAPT Therapeutics, Inc. Total Assets History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$240.3M
FY2024
5-year range
$119.0M / $266.2M
FY2020-FY2024
Trend
+38.7%
vs FY2023
Sector context
#186 of 215
Health Care
What the data says
RAPT Therapeutics, Inc.'s total assets of $240M is lower than 87% of companies in the Health Care sector (FY2024). Declined from $266M to $240M over the past 2 years.
Based on SEC 10-K filings.
$240M in FY2024 with a 5-year CAGR of +23.2%.
Declined from $266M to $240M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.6%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 215This company $240.3M Sector average $7.5B
▼
-96.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.2%, indicating consistent growth.
- In FY2024, total assets increased 38.7% year-over-year.
- Ranks #186 out of 215 companies in the Health Care sector.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $240.3M | +38.7% |
| FY2023 | $173.3M | -34.9% |
| FY2022 | $266.2M | +34.0% |
| FY2021 | $198.6M | +67.0% |
| FY2020 | $119.0M | +40.6% |
| FY2019 | $84.6M | +21.5% |
| FY2018 | $69.6M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026